MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. (MHUAF) Gross margin 2019–2025
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. (MHUAF) gross margin by fiscal year — reported gross profit divided by reported revenue.
31.0%FY2025 · since FY2019: 40.5% → 31.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 31.0% | -3.4 pp |
| FY2024 | 34.4% | +0.2 pp |
| FY2023 | 34.2% | -2.7 pp |
| FY2022 | 36.9% | -1.4 pp |
| FY2021 | 38.3% | -3.5 pp |
| FY2020 | 41.7% | +1.3 pp |
| FY2019 | 40.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MHUAF financial trends
MHUAF RevenueMHUAF Net incomeMHUAF Net marginMHUAF Gross profitMHUAF Operating incomeMHUAF Operating marginMHUAF Operating cash flowMHUAF Free cash flowMHUAF Capital expendituresMHUAF Return on equityMHUAF Stock buybacksMHUAF Dividends paidMHUAF Total assetsMHUAF Total liabilitiesMHUAF Shareholders’ equityMHUAF overview →